| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |